https://www.idealist.org/en/nonprofit/1c32945a3bd34cc4be4c1f6ada370bda-myeloma-canada-montreal
Myeloma Canada - Organization - Idealist
myeloma canadaorganizationidealist
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-talquetamab-tgvs-relapsed-or-refractory-multiple-myeloma
FDA grants accelerated approval to talquetamab-tgvs for relapsed or refractory multiple myeloma |...
On August 9, 2023, the Food and Drug Administration granted accelerated approval to talquetamab-tgvs (Talvey, Janssen Biotech, Inc.)
multiple myelomafdagrantsacceleratedapproval
https://blackdoctor.com/best-multiple-myeloma-treatment-option/
What Is Your Best Multiple Myeloma Treatment Option? - BlackDoctor
Mar 7, 2026 - What Is Your Best Multiple Myeloma Treatment Option? Find out what is multiple myeloma and are treatment options are best for you!
what ismultiple myelomatreatment optionbestblackdoctor
https://ecancer.org/en/news/23180-asco-2023-ciltacabtagene-autoleucel-reduces-risk-of-disease-progression-by-74-in-multiple-myeloma-after-lenalidomide-stops-working
ASCO 2023: Ciltacabtagene autoleucel reduces risk of disease progression by 74% in multiple myeloma...
Ciltacabtagene autoleucel, a BCMA-targeting CAR T-cell therapy, significantly slows or stops progression of multiple myeloma when compared with standard-of-care
disease progressionmultiple myelomaascorisk
https://ctv.veeva.com/study/a-phase-1-open-label-multicenter-dose-escalation-study-of-the-safety-tolerability-and-pk-of-hpn2
Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)
Researchers want to learn if MK-4002 (also known as HPN217) can treat relapsed or refractory multiple myeloma (RRMM). The goals of this study are to learn...
multiple myelomastudyparticipantsrefractorymk
https://www.cancernetwork.com/view/bloodless-transplant-feasible-multiple-myeloma
Is Bloodless Transplant Feasible in Multiple Myeloma? | CancerNetwork
May 19, 2026 - Undergoing bloodless autologous stem cell transplantation could be a viable option for some multiple myeloma patients according to a retrospective study.
multiple myelomabloodlesstransplantcancernetwork
https://curemydisease.com/studies/dreamm-2-belantamab-for-multiple-myeloma-nct03525678-554
DREAMM 2: Belantamab for Multiple Myeloma (NCT03525678)
A phase 2 study testing two doses of belantamab mafodotin in adults with advanced multiple myeloma who have tried multiple prior treatments. NCT ID:...
multiple myelomadreamm
https://int.livhospital.com/hematology/multiple-myeloma/india/
Multiple Myeloma Treatment Cost in India vs Turkey
Explore Multiple Myeloma Treatment cost in India and compare it with Turkey options for Indian patients. Compare local prices with Turkey and discover your...
multiple myelomatreatment costindiavsturkey
https://cancer.osu.edu/blog/patient-becomes-donor-to-help-find-cure-for-multiple-myeloma
Patient Becomes Donor to Help Find Cure for Multiple Myeloma
A multiple myeloma patient is taking an active role in the effort to find a cure for the illness.
to helpmultiple myelomapatientbecomesdonor
https://www.oncolink.org/treatment-binder/codes/mmix
Myeloma - Ixazomib | OncoLink
OncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing...
myeloma
https://www.walkuplawoffice.com/2025/07/02/kaiser-result-failure-to-diagnose-multiple-myeloma/
Kaiser Result: Failure to Diagnose Multiple Myeloma - Walkup, Melodia, Kelly & Schoenberger
Jul 3, 2025 - Confidential Settlement The Walkup Kaiser negligence group negotiated a settlement for a 56-year-old patient who developed kidney failure and required lifetime...
failure to diagnosemultiple myelomakaiserresultmelodia
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/myeloma/roster
Myeloma Steering Committee Roster - NCI
Myeloma Steering Committee Roster
steering committeemyelomarosternci
https://healthtree.org/myeloma/community/articles/stem-cell-transplant-still-improves-myeloma-patient-survival
Stem Cell Transplant Still Improves Myeloma Patient Survival - HealthTree for Multiple Myeloma
Stem cell transplant still prolongs survival for myeloma patients, even in the age of newer therapies. Why aren't more patients getting this treatment?
stem cell transplantpatient survivalstillimprovesmyeloma
https://www.creative-bioarray.com/products/multiple-myeloma-fish-probes-list-530.htm
Multiple Myeloma FISH Probes - Creative Bioarray | Creative Bioarray
Multiple Myeloma FISH probes from Creative Bioarray are specialized research tools designed to detect genetic abnormalities associated with multiple myeloma, a...
multiple myelomafishprobescreative
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.556231.php
Bispecific Antibodies in myeloma: How to Use?
how to usebispecific antibodiesmyeloma
https://scholars.houstonmethodist.org/en/publications/bone-marrow-stromal-cells-derived-mcp-1-reverses-the-inhibitory-e/
Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells...
bone marrowmultiple myelomacellsderivedmcp
https://www.muni.cz/vyzkum/publikace/1107535
Cell Cycle Genes Coexpression in Multiple Myeloma and Plasma Cell Leukemia | Masarykova univerzita...
cell cyclemultiple myelomamasarykova univerzitagenesplasma
https://powerfulpatients.org/resource/understanding-the-role-of-clinical-trials-as-a-myeloma-treatment-option/
Understanding the Role of Clinical Trials As a Myeloma Treatment Option - Patient Empowerment...
Sep 22, 2025 - https://vimeo.com/755523643 When it comes to myeloma treatment options, where do clinical trials fit in? Dr. Melissa Alsina of Moffitt Cancer Center discusses...
understanding therole ofclinical trialstreatment optionpatient empowerment
https://www.texasoncology.com/cancer-care/multiple-myeloma/stages
Stages of Multiple Myeloma | Texas Oncology
Multiple myeloma is staged from I to III based on tumor burden and lab values. Texas Oncology provides expert care, including diagnosis, treatment, and support.
stages ofmultiple myelomatexasoncology
https://www.dana-farber.org/for-physicians/clinical-resources/hematologic-malignancies/advances-newsletter/2013-issue-2/patient-care-spotlight-hypercalcemia-multiple-myeloma
Patient Care Spotlight: Current Management of Hypercalcemia Associated With Multiple Myeloma |...
Discover the latest patient care spotlight on hypercalcemia associated with multiple myeloma and how Dana-Farber is improving patient outcomes.
patient careassociated withmultiple myelomaspotlightcurrent
https://peoplebeatingcancer.org/multiple-myeloma-darzalex-best-among-all-triplet-combinations/
Multiple Myeloma- Darzalex Best Among All Triplet Combinations - PeopleBeatingCancer
Feb 1, 2022 - Since only two agents were found to add a significant cost-effective value to multiple myeloma regimens, the researchers highlighted the need for improved
multiple myelomabestamongtripletcombinations
https://scholars.hkmu.edu.hk/en/publications/cardiovascular-toxicity-of-proteasome-inhibitors-in-multiple-myel/fingerprints/
Cardiovascular Toxicity of Proteasome Inhibitors in Multiple Myeloma Therapy - Fingerprint - Hong...
proteasome inhibitorsmultiple myelomacardiovasculartoxicitytherapy
https://scholars.mssm.edu/en/clippings/fda-approves-carvykti-as-second-car-t-cell-therapy-for-advanced-m/
FDA approves Carvykti as second CAR T-cell therapy for advanced multiple myeloma - Icahn School of...
car tcell therapyfor advancedmultiple myelomafda
https://www.healthwellfoundation.org/realworldhealthcare/tag/multiple-myeloma/
multiple myeloma Archives - HealthWell Foundation
multiple myelomahealthwell foundationarchives
https://www.aitia.com/investigation-of-mechanisms-of-response-in-multiple-myeloma-via-bayesian-causal-inference-an-early-analysis-of-the-commpass-study-data/
Investigation of Mechanisms of Response in Multiple Myeloma Via Bayesian Causal Inference: An Early...
Nov 23, 2023 - Fred Gruber, Boris Hayete, Jonathan Keats, Kyle McBride, Karl Runge, Mary DeRome, Sagar Lonial, Iya Khalil, Daniel Auclair. American Society of Hematology...
multiple myelomacausal inferenceinvestigationmechanismsresponse
https://stanfordhealthcare.org/trials/h/NCT00349778.html
High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.
high dosemultiple myelomasequentialtherapysingle
https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/conference-presentations/2023-conference-presentations/randomized-phase-2-study-of-digital-life-coaching-during-stem-cell-transplantation-for-myeloma
Randomized Phase 2 Study of Digital Life Coaching during Stem Cell Transplantation for Myeloma |...
Poster with the title "Randomized Phase 2 Study of Digital Life Coaching during Stem Cell Transplantation for Myeloma" presented at the 20th International...
stem cell transplantationdigital lifephasestudycoaching
https://kanker-actueel.nl/NL/algemeen-kahler-multiple-myeloma-informatie.html
Algemeen: Kahler - Multiple Myeloma informatie
Algemeen: Kahler - Multiple Myeloma informatie
multiple myelomaalgemeenkahlerinformatie
https://www.justgiving.com/fundraising/Naomi-Robinson14
Naomi and Tash Robinson is fundraising for LEUKAEMIA & MYELOMA RESEARCH UK
naomitashrobinsonfundraisingleukaemia
https://pubmed.ncbi.nlm.nih.gov/35177759/
Time trend and Bayesian mapping of multiple myeloma incidence in Sardinia, Italy
A few reports have described increasing trends and spatial distribution of multiple myeloma (MM). We used a validated database including the 1606 cases of MM...
multiple myelomatimetrendbayesianmapping
https://researchrepository.ucd.ie/entities/publication/4e011e76-dd6f-4f60-8e8e-b2911d30eac3
An investigation into Extracellular Vesicles content and function within the Multiple Myeloma...
Multiple myeloma (MM) is an incurable blood cancer that results from the monoclonal expansion of plasma cells in the bone marrow (BM). The progression of MM...
an investigationextracellular vesiclesthe multiplecontentfunction
https://bpno.no/medtalks/a-potential-new-standard-of-care-for-transplant-eligible-patients-with-multiple-myeloma/
A potential new standard of care for transplant-eligible patients with Multiple Myeloma
Aug 5, 2024 - Pieter Sonneveld discussed in this MEDtalk the PERSEUS trial presented at ASH 2023. The study involved 700 patients across 13 countries and showed promising...
standard of caremultiple myelomapotentialnewtransplant
https://ascopost.com/issues/december-1-2014/hdac-inhibitors-and-triple-therapy-in-relapsed-myeloma/
HDAC Inhibitors and Triple Therapy in Relapsed Myeloma - The ASCO Post
hdac inhibitorstriple therapymyelomaascopost
https://cancerchat.cancerresearchuk.org/f/caring-for-someone-with-cancer/129048/my-sister-s-just-been-diagnosed-with-multiple-myeloma-how-can-i-best-support-her-both-physically-and-emotionally
My Sister's just been diagnosed with multiple myeloma. How can I best support her both, physically...
My Sister was diagnosed with Multiple Myeloma 8 days ago, our family and close friends feel very concerned and worried for her. She is on lots of strong meds...
just been diagnosedmultiple myelomasisterbestsupport
https://arizonaccc.com/service/multiple-myeloma/
Multiple Myeloma - Arizona Center for Cancer Care
multiple myelomacancer carearizonacenter
https://www.siemens-healthineers.com/hu/plasma-protein/webinars/flc-testing-multiple-myeloma-kidney-disease-chinese-perspective
FLC testing in multiple myeloma and kidney disease: A Chinese Perspective - Siemens Healthineers...
This session explores a Chinese perspective on the current role of FLC testing in MM, and considers the influence of kidney function on FLC test result.
multiple myelomakidney diseasesiemens healthineersflctesting
https://www.panabee.com/news/arcellx-announces-positive-phase-2-data-for-multiple-myeloma-treatment
Arcellx Announces Positive Phase 2 Data for Multiple Myeloma Treatment | ACLX Financial News
Arcellx announced positive Phase 2 clinical trial data for its multiple myeloma treatment, anito-cel, and will present updated data at the American Society of...
multiple myelomafinancial newsarcellxannouncespositive
https://medcode.ch/ca/en/icds/ICD-10-CM-2018/C90
ICD-10-CM 2018: C90 Multiple myeloma and malignant plasma cell neop...
multiple myelomaicdcmmalignantplasma
https://www.lymphomapet.com/
10th international workshop on PET in lymphoma and myeloma (PILM 2025)
The 9th international workshop on PET in lymphoma and myeloma will be held on line on October 6-7, 2023 (see preliminary program). Registration are open now.
international workshoppetlymphomamyeloma
https://researchportal.vub.be/nl/publications/unveiling-b7-h3-as-novel-target-for-car-t-cell-therapy-in-multipl/
Unveiling B7-H3 as novel target for CAR T-cell therapy in Multiple Myeloma - Vrije Universiteit...
for carcell therapymultiple myelomavrije universiteitunveiling
https://www.cms.gov/medicare-coverage-database/view/ncacal-public-comments.aspx?ncaid=237&
NCA - Positron Emission Tomography for Initial Treatment Strategy in Solid Tumors and Myeloma...
Use this page to nca - positron emission tomography for initial treatment strategy in solid tumors and myeloma (cag-00181r3) - view public comments.
positron emissioninitial treatmentsolid tumorsncatomography
https://oncodaily.com/voices/myeloma-paper-of-the-day-443684
Myeloma Paper of the Day, January 19th, Suggested by Robert Orlowski - OncoDaily
Jan 19, 2026 - Myeloma Paper of the Day, January 19th, Suggested by Robert Orlowski / Ahmedin Jemal, cancer, Hyuna Sung, Myeloma, Myeloma Paper of the Day, Nikita Sandeep
of the daymyelomapaperjanuarysuggested
https://research.universityofgalway.ie/en/publications/multiple-myeloma-and-other-differentiated-b-cell-disorders-3/
Multiple myeloma and other differentiated B-cell disorders. - University of Galway
university of galwaymultiple myelomabcelldisorders
https://outcomes4me.com/patient/community/Surgery-and-Recovery/post/escuzr/multiple-myeloma-affect-vision-hearing
Does multiple myeloma affect vision or hearing? | Outcomes4Me Community
Does anyone have multiple myeloma? Does it affect your vision, or hearing?
multiple myelomaaffectvisionhearingcommunity
https://air.unipr.it/handle/11381/2873635
CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment:...
the contextbone marrowexpressionmyelomacells
https://research.tilburguniversity.edu/en/publications/chemotherapy-induced-neuropathy-in-multiple-myeloma-influence-on-/
Chemotherapy-induced neuropathy in multiple myeloma: Influence on quality of life and development...
quality of lifemultiple myelomachemotherapyneuropathyinfluence
https://kris.kl.ac.at/en/publications/cure-for-multiple-myeloma/
Cure for multiple myeloma? - Karl Landsteiner University
multiple myelomakarl landsteinercureuniversity
https://repository.icr.ac.uk/items/34535842-f4c6-4819-93d8-1b9838ee2d1d
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group...
Primary plasma cell leukemia (PCL) has a consistently ominous prognosis, even after progress in the last decades. PCL deserves a prompt identification to start...
the internationalworking groupprimaryplasmacell
https://pure.fujita-hu.ac.jp/ja/publications/prediction-of-mobilized-hematopoietic-stem-cell-yield-in-patients/
Prediction of mobilized hematopoietic stem cell yield in patients with multiple myeloma: Usefulness...
stem cellin patientsmultiple myelomapredictionyield
https://www.bioworld.com/articles/720805-ldhal6b-identified-as-a-prognostic-biomarker-in-multiple-myeloma?v=preview
LDHAL6B identified as a prognostic biomarker in multiple myeloma | BioWorld
Multiple myeloma (MM) is a complex and heterogeneous blood cancer, and current risk assessment tools like the Revised International Staging System (R-ISS) have...
as amultiple myelomaidentifiedbiomarkerbioworld
https://ece.northsouth.edu/capstone-design/myeloma-dieseas-detection-using-deep-learning/
Myeloma Dieseas detection using deep learning - Department of Electrical and Computer Engineering
deep learningdepartment ofcomputer engineeringmyelomadetection
https://www.macmillan.org.uk/cancer-information-and-support/diagnostic-tests/blood-tests-for-myeloma
Blood tests for myeloma | Macmillan Cancer Support
Myeloma blood tests help diagnose and monitor myeloma. We explain the key tests and what they show, including serum protein electrophoresis.
macmillan cancer supportblood testsmyeloma
https://avesis.hacettepe.edu.tr/yayin/641b24be-8ffc-42d9-8848-b5f8ac9019e4/evaluation-of-the-survival-outcomes-of-multiple-myeloma-patients-according-to-their-plasmacytoma-presentation-at-diagnosis
Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma...
survival outcomesmultiple myelomaaccording toevaluationpatients
https://einstein.elsevierpure.com/en/publications/characterization-of-central-nervous-system-multiple-myeloma-in-th/
Characterization of central nervous system multiple myeloma in the era of novel therapies - Albert...
central nervous systemmultiple myelomathe eranovel therapiescharacterization
https://multiplemyeloma.org.nz/zoom-catch-up-support-group/
Zoom catch up/support group | Multiple Myeloma
catch upsupport groupmultiple myelomazoom
https://www.frontiersin.org/research-topics/71130/advances-in-immunotherapy-and-molecular-characterization-of-multiple-myeloma/authors
Frontiers | Advances in Immunotherapy and Molecular Characterization of Multiple Myeloma
Multiple myeloma (MM) remains a complex and heterogeneous hematologic malignancy with evolving therapeutic challenges. In recent years, immunotherapy has eme...
multiple myelomafrontiersadvancesimmunotherapymolecular
https://ubiehealth.com/doctors-note/period-back-pain-multiple-myeloma
Could multiple myeloma be the reason for increased back pain during my period? | Ubie Doctor's Note
Increased back pain during your period is often linked to menstrual disorders and not typically to multiple myeloma.
be the reasonmultiple myelomaback paincouldincreased
https://haematologica.org/article/view/7399
Health-related quality of life in patients with multiple myeloma - does it matter? | Haematologica
quality of lifehealth relatedin patientsmultiple myelomamatter
https://www.birminghammedicalnews.com/article/9377/men-more-likely-to-develop-multiple-myeloma-than-women
Men More Likely to Develop Multiple Myeloma than Women - Birmingham Medical News
Multiple myeloma, the second most common blood cancer in the United States, is more common in men with an estimated 20,030 new male cases in 2025. The reasons...
more likelymultiple myelomamedical newsmendevelop
https://www.jobsandcareersasia.com/article/854593903-the-international-myeloma-foundation-welcomes-heather-cooper-ortner-as-new-president-ceo
The International Myeloma Foundation Welcomes Heather Cooper Ortner as New President & CEO | Jobs &...
the internationalheather coopermyelomafoundationwelcomes
https://www.veteducator.com/document-tag/mucosal-plasma-cell-myeloma/
Mucosal plasma cell myeloma Archives - VetEducator
mucosalplasmacellmyelomaarchives
https://www.cancercare.org/questions/tagged/multiple_myeloma
Multiple Myeloma, Treatments
Experts answer questions about multiple myeloma treatments, your diagnosis and other cancer related questions.
multiple myelomatreatments
https://www.aacr.org/blog/2015/03/03/fda-approval-panobinostat-epigenetic-targeted-therapeutic/
Epigenetic Research Yields New Multiple Myeloma Therapeutic - American Association for Cancer...
Mar 3, 2015 - The FDA recently approved a new epigenetic-targeted therapeutic called panobinostat (Farydak) for certain patients with multiple myeloma.
multiple myelomaamerican associationepigeneticresearchyields
https://www.jadpro.com/issues/volume-5-number-3-mayjun-2014/innovative-agents-in-multiple-myeloma/
JADPRO | Innovative Agents in Multiple Myeloma
multiple myelomainnovativeagents
https://www.maxlab.co.in/lab-test/profile/kanpur/ramaipur/myeloma-profile-new
Book Myeloma Profile Test in Ramaipur, Kanpur - Price, Sample Collection | Max Lab
Book Myeloma Profile Test in Ramaipur, Kanpur online with home sample collection facility from Max Lab by Max Hospital at best cost/rate. Certified Labs,...
sample collectionbookmyelomaprofiletest
https://cbirt.net/an-improved-method-for-detecting-myeloma-bone-disease-using-deep-learning-coupled-photon-counting-ct/
Detecting Myeloma Bone Disease using Deep Learning Coupled Photon-counting CT - CBIRT
Sep 13, 2022 - Scientists have developed a new CT technique using artificial intelligence (AI) to spot multiple myeloma-related bone diseases.
photon counting ctbone diseasedeep learningdetectingmyeloma
https://secure.medicalletter.org/TML-article-1495d
Three New Drugs for Multiple Myeloma (online only) | The Medical Letter Inc.
The Medical Letter has provided trusted prescription drug information and drug facts since 1959
new drugsmultiple myelomaonline onlythreemedical
https://www.jci.org/assets/324189/powerpoint
JCI - Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells
multiple myelomajciantibodydrugconjugate
https://bloodjournal.ru/index.php/coh/en/article/view/36?articlesBySameAuthorPage=3
Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients Aged...
stem cell transplantationmultiple myelomaefficacyautologouspatients
https://scholars.depaul.edu/en/publications/lack-of-health-maintenance-examinations-and-risk-in-myeloma-patie/
Lack of health maintenance examinations and risk in myeloma patients - DePaul University Research...
health maintenancedepaul universitylackexaminationsrisk
https://www.uc.edu/news/articles/2024/03/everyday-health--ways-to-manage-symptoms-linked-to-multiple-myeloma.html
EveryDay Health: Ways to manage symptoms linked to multiple myeloma - University of Cincinnati:...
Mar 26, 2024 - The University of Cincinnati's Ed Faber spoke with EveryDay Health about ways to manage symptoms of multiple myeloma including numbness, pain or tingling in...
university of cincinnatieveryday healthmanage symptomsmultiple myelomaways
https://www.oaepublish.com/articles/cdr.2018.04
Drug targets and resistance mechanisms in multiple myeloma
Multiple myeloma (MM), a malignancy of plasma cells, is the second most prevalent blood cancer (10%). A PubMed search has been conducted for English research...
drug targetsmultiple myelomaresistancemechanisms